Panadol Osteo to stay delisted

white pills - look like codeine combination OTCs
The PBAC has reaffirmed its decision that Panadol Osteo should be delisted. “The PBAC assessed the issues raised in the correspondence, but did not consider that there was any basis to revisit its earlier recommendations in this regard,” it has said in outlining the outcome of its consideration on the fate of the medicine. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A question of ethics
Next Monitoring about to get real